| Code | Display | Definition |
| ABVD |
ABVD |
Bleomycin, Dacarbazin, Doxorubicin, Vinblastin |
| AC |
AC |
Cyclophosphamid, Doxorubicin |
| ACO |
ACO |
Cyclophosphamid, Doxorubicin, Vincristin |
| ADORE |
ADORE |
Fluorouracil, Folinsäure, Oxaliplatin |
| ADR-IFO |
ADR-IFO |
Doxorubicin, Ifosfamid, Mesna |
| AIO |
AIO |
Fluorouracil, Folinsäure |
| AIO-04 |
AIO-04 |
Fluorouracil, Folinsäure, Oxaliplatin |
| AIO-Irinotecan |
AIO-Irinotecan |
Fluorouracil, Folinsäure, Irinotecan |
| ARO |
ARO |
Fluorouracil, Folinsäure, Oxaliplatin |
| AVD |
AVD |
Dacarbazin, Doxorubicin, Vinblastin |
| BCD |
BCD |
Actinomycin D, Bleomycin, Cyclophosphamid |
| BEACOPP-basis |
BEACOPP basis |
Bleomycin, Cyclophosphamid, Doxorubicin, Etoposid, Procarbazin, Vincristin, Prednison |
| BEACOPP-eskaliert |
BEACOPP eskaliert |
Bleomycin, Cyclophosphamid, Doxorubicin, Etoposid, Procarbazin, Vincristin, Prednison |
| BEAM |
BEAM |
BCNU, Cytarabin, Etoposid, Melphalan |
| BOLD |
BOLD |
Bleomycin, Dacarbazin, Lomustin, Vincristin |
| BP |
BP |
Bendamustin, Prednison |
| BR |
BR |
Bendamustin, Rituximab |
| BrECADD |
BrECADD |
Brentuximab, Cyclophosphamid, Dacarbacin, Doxorubicin, Etoposid, Dexamethason |
| BuCy |
BuCy |
Busulfan, Cyclophosphamid |
| CAD |
CAD |
Cyclophosphamid, Doxorubicin, Dexamethason |
| CAO |
CAO |
Fluorouracil, Folinsäure, Oxaliplatin |
| CapeOx |
CapeOx |
Capecitabin, Oxaliplatin |
| Cap-Schema |
Cap-Schema |
Capecitabin |
| CarboTax |
CarboTax |
Carboplatin, Paclitaxel |
| CEV |
CEV |
Carboplatin, Etoposid, Vincristin |
| CHOEP |
CHOEP |
Cyclophosphamid, Doxorubicin, Etoposid, Vincristin, Prednison |
| CHOEP-14 |
CHOEP-14 |
Cyclophosphamid, Doxorubicin, Etoposid, Vincristin, Prednison, G-CSF |
| CHOEP-21 |
CHOEP-21 |
Cyclophosphamid, Doxorubicin, Etoposid, Vincristin, Prednison, G-CSF |
| CHOP |
CHOP |
Cyclophosphamid, Doxorubicin, Vincristin, Prednison |
| CHOP-14 |
CHOP-14 |
Cyclophosphamid, Doxorubicin, Vincristin, Prednison, G-CSF |
| CHOP-21 |
CHOP-21 |
Cyclophosphamid, Doxorubicin, Vincristin, Prednison, G-CSF |
| CMF |
CMF |
Cyclophosphamid, Fluorouracil, Methotrexat |
| COPP |
COPP |
Cyclophosphamid, Procarbazin, Vincristin, Prednison |
| CV |
CV |
Cisplatin, Vinorelbin |
| DA |
DA |
Cytarabin, Daunorubicin |
| DAC |
DAC |
Cyclophosphamid, Docetaxel, Doxorubicin |
| DC-Doce-Carbo |
DC (Doce/Carbo) |
Carboplatin, Docetaxel |
| DC-Doce-Cyclo |
DC (Doce/Cyclo) |
Cyclophosphamid, Docetaxel |
| DCbH |
DCbH |
Carboplatin, Docetaxel, Trastuzumab |
| DeVIC |
DeVIC |
Carboplatin, Etoposid, Ifosfamid, Dexamethason |
| Dexa-BEAM |
Dexa-BEAM |
Carmustin, Cytarabin, Etoposid, Melphalan, Dexamethason |
| DHAP |
DHAP |
Cisplatin, Cytarabin, Dexamethason |
| DRC |
DRC |
Cyclophosphamid, Rituximab, Dexamethason |
| DVP |
DVP |
Cisplatin, Dacarbazin, Vindesin |
| EC |
EC |
Cyclophosphamid, Epirubicin |
| EC-D |
EC-D |
Cyclophosphamid, Docetaxel, Epirubicin |
| ECF |
ECF |
Cisplatin, Epirubicin, Fluorouracil |
| EC-P |
EC-P |
Cyclophosphamid, Epirubicin, Paclitaxel |
| ELO-Rd |
ELO-Rd |
Elotuzumab, Lenalidomid, Dexamethason |
| EOX |
EOX |
Capecitabin, Epirubicin, Oxaliplatin |
| EXTREME-mit-Carboplatin |
EXTREME mit Carboplatin |
Carboplatin, Cetuximab, Fluorouracil |
| EXTREME-mit-Cisplatin |
EXTREME mit Cisplatin |
Cetuximab, Cisplatin, Fluorouracil |
| FAC |
FAC |
Cyclophosphamid, Doxorubicin, Fluorouracil |
| FC |
FC |
Cyclophosphamid, Fludarabin |
| FCR |
FCR |
Cyclophosphamid, Fludarabin, Rituximab |
| FEC |
FEC |
Cyclophosphamid, Epirubicin, Fluorouracil |
| FEC-Doc |
FEC-Doc |
Cyclophosphamid, Docetaxel, Epirubicin, Fluorouracil |
| FLAG-Ida |
FLAG-Ida |
Cytarabin, Fludarabin, Idarubicin, Lenogastrim |
| FLO |
FLO |
Fluorouracil, Folinsäure, Oxaliplatin |
| FLOT |
FLOT |
Docetaxel, Fluorouracil, Folinsäure, Oxaliplatin |
| Flu-Cam |
Flu-Cam |
Alemtuzumab, Fludarabin |
| FOLFIRI |
FOLFIRI |
Fluorouracil, Folinsäure, Irinotecan |
| Folfirinox |
Folfirinox |
Fluorouracil, Folinsäure, Irinotecan, Oxaliplatin |
| FOLFOX4 |
FOLFOX4 |
Fluorouracil, Folinsäure, Oxaliplatin |
| FOLFOX-6 |
FOLFOX-6 |
Fluorouracil, Folinsäure, Oxaliplatin |
| FOLFOXIRI |
FOLFOXIRI |
Fluorouracil, Folinsäure, Irinotecan, Oxaliplatin |
| FUFAMI |
FUFAMI |
Fluorouracil, Folinsäure, Mitomycin |
| FUFIRI |
FUFIRI |
Fluorouracil, Folinsäure, Irinotecan |
| FUFOX |
FUFOX |
Fluorouracil, Folinsäure, Oxaliplatin |
| GC-B |
GC-B |
Bevacizumab, Carboplatin, Gemcitabin |
| GDP-Schema |
GDP-Schema |
Cisplatin, Gemcitabin, Dexamethason |
| GELOX |
GELOX |
Asparaginase, Gemcitabin, Oxaliplatin |
| Gem-Carbo |
Gem-Carbo |
Carboplatin, Gemcitabin |
| Gem-Cis |
Gem-Cis |
Cisplatin, Gemcitabin |
| GemTreo |
GemTreo |
Gemcitabin, Treosulfan |
| GOP |
GOP |
Gemcitabin, Oxaliplatin, Paclitaxel |
| HAM-Cytarabin |
HAM-Cytarabin |
Cytarabin, Mitoxantron |
| HD-Protokoll |
HD-Protokoll |
BCNU, Rituximab, Thiotepa |
| ICE |
ICE |
Carboplatin, Etoposid, Ifosfamid |
| IEV |
IEV |
Epirubicin, Etoposid, Ifosfamid |
| IMVP-16 |
IMVP-16 |
Etoposid, Ifosfamid, Methotrexat |
| IRd |
IRd |
Ixazomib, Lenalidomid, Dexamethason |
| Knospe |
Knospe |
Chlorambucil, Prednison |
| Knospe-modifiziert |
Knospe modifiziert |
Chlorambucil, Rituximab |
| KRD |
KRD |
Carfilzomib, Lenalidomid, Dexamethason |
| LV5FU2 |
LV5FU2 |
Fluorouracil, Folinsäure |
| LV5FU2-modif |
LV5FU2 modif. |
Fluorouracil, Folinsäure |
| MAMAC |
MAMAC |
Amsacrin, Cytarabin |
| MATRix |
MATRix |
Cytarabin, Methotrexat, Rituximab, Thiotepa |
| MAV |
MAV |
Cytarabin, Etoposid, Mitoxantron |
| Mayo-Protokoll |
Mayo-Protokoll |
Fluorouracil, Folinsäure |
| M-Cavi |
M-Cavi |
Carboplatin, Methotrexat, Vinblastin |
| MPT |
MPT |
Melphalan, Thalidomid, Prednison |
| M-VAC |
M-VAC |
Cisplatin, Doxorubicin, Methotrexat, Vinblastin |
| PAC |
PAC |
Cisplatin, Cyclophosphamid, Doxorubicin |
| PC |
PC |
Bevacizumab, Carboplatin, Paclitaxel |
| PC-mit-Bevacizumab |
PC mit Bevacizumab |
Bevacizumab, Carboplatin, Paclitaxel |
| PC-ohne-Bevacizumab |
PC ohne Bevacizumab |
Carboplatin, Paclitaxel |
| PCV |
PCV |
Lomustin, Procarbazin, Vincristin |
| PE |
PE |
Cisplatin, Etoposid |
| PEB |
PEB |
Bleomycin, Cisplatin, Etoposid |
| Peg-DoxC |
Peg. DoxC |
Carboplatin, Doxorubicin |
| PEI |
PEI |
Cisplatin, Etoposid, Ifosfamid |
| P-GEMOX |
P-GEMOX |
Asparaginase (peg), Gemcitabin, Oxaliplatin |
| PLF |
PLF |
Cisplatin, Fluorouracil, Folinsäure |
| PVAG-Schema |
PVAG-Schema |
Doxorubicin, Gemcitabin, Vinblastin, Prednison |
| PVBI |
PVBI |
Cisplatin, Ifosfamid, Vinblastin |
| R-BAC |
R-BAC |
Bendamustin, Cytarabin, Rituximab |
| R-Bendamustin |
R-Bendamustin |
Bendamustin, Rituximab |
| R-CHOP |
R-CHOP |
Cyclophosphamid, Doxorubicin, Vincristin, Rituximab, Prednison |
| R-DeVIC |
R-DeVIC |
Carboplatin, Etoposid, Ifosfamid, Rituximab, Dexamethason |
| R-DHAP |
R-DHAP |
Cisplatin, Cytarabin, Rituximab, Dexamethason |
| RD-Schema |
RD-Schema |
Lenalidomid, Dexamethason |
| RevDex |
Rev/Dex |
Lenalidomid, Dexamethason |
| R-GemOx |
R-GemOx |
Gemcitabin, Oxaliplatin, Rituximab |
| R-HAD |
R-HAD |
Cytarabin, Rituximab, Dexamethason |
| R-ICE |
R-ICE |
Carboplatin, Etoposid, Ifosfamid, Rituximab |
| R-MCP |
R-MCP |
Chlorambucil, Mitoxantron, Rituximab, Prednison |
| R-MP |
R-MP |
Methotrexat, Procarbazin, Rituximab |
| S-HAI |
S-HAI |
Cytarabin, Idarubicin, G-CSF |
| S-HAM |
S-HAM |
Cytarabin, Mitoxantron, G-CSF |
| SMILE |
SMILE |
Asparaginase, Etoposid, Ifosfamid, Methotrexat, Dexamethason |
| TAC |
TAC |
Cyclophosphamid, Docetaxel, Doxorubicin |
| TCED |
TCED |
Cyclophosphamid, Etoposid, Thalidomid, Dexamethason |
| TCH |
TCH |
Carboplatin, Docetaxel, Trastuzumab |
| TIP |
TIP |
Cisplatin, Ifosfamid, Paclitaxel |
| TMZ |
TMZ |
Temozolomid |
| TPF |
TPF |
Cisplatin, Docetaxel, Fluorouracil |
| VCD |
VCD |
Bortezomib, Cyclophosphamid, Dexamethason |
| VFD |
VFD |
Bortezomib, Panobinostat, Dexamethason |
| VIPD |
VIPD |
Carboplatin, Etoposid, Ifosfamid, Dexamethason |
| VMP |
VMP |
Bortezomib, Melphalan, Prednison |
| VRD |
VRD |
Bortezomib, Lenalidomid, Dexamethason |
| VTD |
VTD |
Bortezomib, Thalidomid, Dexamethason |
| XELOX |
XELOX |
Capecitabin, Oxaliplatin |
| XP |
XP |
Capecitabin, Cisplatin |
| Konditionierung-aemyeloablativ-MAC |
Konditionierung, ämyeloablativ (MAC) |
Individuell zu wählende Substanzen |
| Konditionierung-nicht-myeloablativ-NMA |
Konditionierung, nicht myeloablativ (NMA) |
Individuell zu wählende Substanzen |
| Konditionierung-reduzierte-Intensitaet-RIC |
Konditionierung, reduzierte Intensität (RIC) |
Individuell zu wählende Substanzen |
| Konditionierung-reduzierte-Toxizitaet-RTC |
Konditionierung, reduzierte Toxizität (RTC) |
Individuell zu wählende Substanzen |
| TACE-Doxorubicin-Mitomycin |
TACE Doxorubicin-Mitomycin |
Doxorubicin, Mitomycin |
| TACE-Doxorubicin |
TACE Doxorubicin |
Doxorubicin |
| TACE |
TACE |
Individuell zu wählende Substanzen |
| HIPEC-Cisplatin-Mitomycin |
HIPEC Cisplatin-Mitomycin |
Cisplatin, Mitomycin |
| HIPEC-Mitomycin |
HIPEC Mitomycin |
Mitomycin |
| HIPEC |
HIPEC |
Individuell zu wählende Substanzen |
| HITOC |
HITOC |
Individuell zu wählende Substanzen |
| PIPAC-Cisplatin-Doxorubicin |
PIPAC Cisplatin-Doxorubicin |
Cisplatin, Doxorubicin |
| PIPAC-Cisplatin-Paclitaxel |
PIPAC Cisplatin-Paclitaxel |
Cisplatin, Paclitaxel |
| PIPAC |
PIPAC |
Individuell zu wählende Substanzen |
| Instillation-Harnblase-Mitomycin |
Instillation Harnblase Mitomycin |
Mitomycin |
| Instillation-Harnblase-Doxorubicin |
Instillation Harnblase Doxorubicin |
Doxorubicin |
| Instillation-Harnblase-Chemotherapeutikum |
Instillation Harnblase Chemotherapeutikum |
Individuell zu wählende Substanzen |
| Instillation-Harnblase-BCG |
Instillation Harnblase (BCG) |
BCG |
| Instillation-Intrathekal-Tripel |
Instillation Intrathekal Tripel |
Cytarabin, Methotrexat, Dexamethason |
| Instillation-Intrathekal-Quadrupel |
Instillation Intrathekal Quadrupel |
Cytarabin, Methotrexat, Dexamethason, Rituximab |
| Instillation-intrathekal |
Instillation intrathekal |
Individuell zu wählende Substanzen |
| PUVA-systemisch-oral |
PUVA systemisch oral |
Psoralen |
| Bade-PUVA-topisch |
(Bade-) PUVA (topisch) |
Psoralen |
| Aderlass |
Aderlass |
Aderlass |
| Leukapherese |
Leukapherese |
Leukapherese |
| Plasmapherese |
Plasmapherese |
Plasmapherese |
| TTFields |
TTFields |
TTFields |
| CAR-T-Zelltherapie |
CAR-T-Zelltherapie |
Individuell zu wählende Substanzen |